| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 22.09. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln | |||||
| 22.09. | BioHarvest sichert sich 10,9 Mio. US-Dollar und stärkt Bilanz durch Schuldenabbau | 1 | Investing.com Deutsch | ||
| 22.09. | BioHarvest raises $10.9 million through warrant exercises and debt conversions | 1 | Investing.com | ||
| 22.09. | BioHarvest Sciences Inc.: BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction | 237 | Newsfile | Rehovot, Israel--(Newsfile Corp. - September 22, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pioneering its patented Botanical Synthesis... ► Artikel lesen | |
| 10.09. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 10.09. | BioHarvest produces plant-based exosomes in bioreactors | 2 | Investing.com | ||
| 10.09. | BioHarvest Sciences Inc.: BioHarvest Sciences Announces Breakthrough in Botanical Synthesis Capabilities with Plant-Based Exosome Production at Scale | 221 | Newsfile | Rehovot, Israel--(Newsfile Corp. - September 10, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 08.09. | Bioharvest Sciences Inc (2): Bioharvest files registration statement on Form F-3 | 1 | Stockwatch | ||
| 02.09. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 02.09. | BioHarvest Sciences Inc.: BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET | 276 | Newsfile | Rehovot, Israel--(Newsfile Corp. - September 2, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 14.08. | Bioharvest Sciences Inc (2): Bioharvest extends insider trading window | 2 | Stockwatch | ||
| 13.08. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.08. | BioHarvest Clears Breakeven on Q2 Numbers | 1 | Baystreet.ca | ||
| 11.08. | BioHarvest Sciences Inc.: BioHarvest Sciences Reports Second Quarter 2025 Financial Results | 400 | Newsfile | Rehovot, Israel--(Newsfile Corp. - August 11, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 11.08. | BioHarvest Sciences GAAP EPS of -$0.24 misses by $0.13, revenue of $8.5M misses by $0.03M | 3 | Seeking Alpha | ||
| 05.08. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 04.08. | BioHarvest Sciences Inc.: BioHarvest Sciences to Host Second Quarter 2025 Earnings Call on August 11 at 8:00 a.m. Eastern Time | 394 | Newsfile | Rehovot, Israel--(Newsfile Corp. - August 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 23.07. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | BIOHARVEST SCIENCES INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 23.07. | BioHarvest Sciences Inc.: BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025 | 302 | Newsfile | Rehovot, Israel--(Newsfile Corp. - July 23, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 27,775 | +0,71 % | Bayer-Aktie: Kommt jetzt die Wende? Kursziel 40 Euro in Sicht! | © Foto: Foto von Roger Bradshaw auf UnsplashDer Pharma- und Chemiekonzern aus Leverkusen steht möglicherweise vor einem spannenden Wendepunkt.Während die Glyphosat-Klagen noch immer wie ein Schatten... ► Artikel lesen | |
| PFIZER | 21,325 | +0,12 % | Warum dieser Strukturwandel in der Medizin Novo Nordisk, PanGenomic Health und Pfizer zu Must-Haves macht | Die Medizin von morgen denkt nicht in Krankheiten, sondern in Chancen. Ein radikaler Wandel von der Reparatur zur vorausschauenden Prävention revolutioniert den Gesundheitssektor und eröffnet massive... ► Artikel lesen | |
| MERCK KGAA | 115,05 | -0,17 % | UBS stuft MERCK KGAA auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Merck KGaA nach dem Kapitalmarkttag von 154 auf 150 Euro gesenkt, aber die Einstufung auf "Buy" belassen. Matthew Weston reduzierte... ► Artikel lesen | |
| AURORA CANNABIS | 4,515 | +0,11 % | Aurora Cannabis Inc (3): Aurora Cannabis to issue Q2 fiscal 2026 results Nov. 5 | ||
| CANOPY GROWTH | 1,152 | -0,86 % | Cannabis-Aktien mit Trump-Schub: Bioxyne, Aurora und Canopy Growth im Fokus | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,285 | +0,59 % | Tilray Brands, Inc.: Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work | ||
| BRISTOL-MYERS SQUIBB | 37,650 | -0,11 % | PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now? | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| DERMAPHARM | 33,200 | +1,37 % | Kurs der Dermapharm-Aktie verharrt auf Vortags-Niveau (31,85 €) | Der Kurs der der Dermapharm-Aktie kommt kaum von der Stelle. Der jüngste Kurs betrug 31,85 Euro. Ein geringes Minus von 0,78 Prozent zeigt die Kurstafel für der Anteilsschein von Dermapharm an. Die... ► Artikel lesen | |
| CRONOS GROUP | 2,222 | +2,30 % | Cronos Group Inc: Cronos Group to hold Q3 2025 results call Nov. 6 | ||
| EYEPOINT PHARMACEUTICALS | 10,275 | -0,19 % | EyePoint Pharmaceuticals, Inc.: EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU in Diabetic Macular Edema | - DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 - - New preclinical... ► Artikel lesen | |
| INCYTE | 78,72 | +0,31 % | Incyte gibt Ergebnisse der Phase-1-Studien zu seinem bispezifischen PD-1/TGFßR2-Antikörper bei fortgeschrittenem kolorektalen Karzinom und zum KRAS-G12D-Inhibitor beim fortgeschrittenen Pankreasduktaladenokarzinom bekannt | Auf der ESMO 2025 präsentierte Daten zeigen, dass INCA33890, ein bispezifischer PD-1/TGFßR2-Antikörper, das Potenzial für eine wirksame Behandlung von kolorektalem Krebs mit stabilen Mikrosatelliten... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,490 | -1,32 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,635 | +1,76 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 |